Skip to content

Well-Being After Breast Cancer Surgery

Improving Well-Being for Individuals With Persistent Pain After Surgery for Breast Cancer, Lobular Carcinoma in Situ, or Ductal Carcinoma in Situ: A Randomized Clinical Trial That Compares Three Behavioral Intervention Strategies and Examines Psychological Factors as Drivers of the Continuing Burden of Persistent Pain

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04225585
Acronym
WB ABCs
Enrollment
316
Registered
2020-01-13
Start date
2021-06-08
Completion date
2026-03-11
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coping Skills Training for Persistent Post-Surgical Pain, General Health Education

Brief summary

The purpose of this study is to compare the benefits of skills training and health education interventions designed specifically to increase the well-being of people with persistent pain after breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer, and to examine the roles of psychological and physiological variables as modifiable contributors to the continuing burden of persistent pain.

Detailed description

Persistent pain following breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer is increasingly recognized as an important clinical and public health issue due to the large number of women affected, the powerful negative impact that persistent pain has on emotional and physical functioning and its financial costs. Most of the more than a quarter of a million women newly diagnosed with breast cancer in the U.S. this year will undergo surgery as a part of curative treatment. The prevalence of persistent pain following surgical removal of the affected breast (mastectomy) or more limited surgeries (lumpectomy) is high, ranging from 25-60% across studies. Unlike acute post-operative pain, which is a normal response to surgical trauma, persistent pain at or near the surgical site has an uncertain multifaceted etiology, and no satisfactory pharmacological treatment. A critical question is whether key pain-related psychosocial factors are drivers of the continuing burden of persistent pain, and whether they could be ameliorated by non-pharmacological intervention. The research planned under this award will provide a first critical test of the hypothesized driving role of pain catastrophizing in persistent pain after breast surgery. It also will explore the role of two other key psychosocial variables that may contribute to the burden associated with persistent pain after breast cancer surgery: self-efficacy for engaging in valued activities and psychological inflexibility. We have developed, manualized, and pilot tested a pain coping skills training intervention that specifically targets the needs of women with persistent pain following breast cancer surgery (CST-PSP) and aims to reduce pain catastrophizing, increase self-efficacy for engaging in valued activities, and increase psychological flexibility. We propose a multiple-site, randomized clinical trial to evaluate the efficacy of the CST-PSP intervention, as well as a health education intervention. The study will be conducted in diverse oncology clinics affiliated with Duke University/Duke Cancer Network and the University of Pittsburgh/UPMC Hillman Cancer Center. Participants (N=316) will be randomized to either receive: 1) CST-PSP, 2) health education with an interventionist, or 3) self-guided health education . Participants will complete assessments pre-intervention and at 3 months (post-intervention), 6 months follow-up, and 12 months follow-up. Study aims are: Aim 1: Examine the impact of intervention programs on persistent post-surgical pain severity and interference (i.e., PEG score), emotional distress (anxiety and depression), and cancer-specific distress. Aim 2: Investigate the impact of intervention programs on pain catastrophizing, pain self-efficacy, and psychological inflexibility, and evaluate these variables as possible mediators of the intervention benefits. Aim 3: Evaluate the impact of intervention programs on pain sensitivity and central sensitization, and explore whether changes in these variables mediate group differences in pain severity and interference.

Interventions

BEHAVIORALCST-PSP

skills training and experiential learning exercises

BEHAVIORALGeneral health education

general health education intervention that focuses on improving overall health

Sponsors

Duke University
Lead SponsorOTHER
University of Pittsburgh Medical Center
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Study staff conducting assessments will be blind to group assignment. To maintain blinding, we will use the following approaches: 1) all study staff will be trained on the importance of blinding and study procedures to maintain blinding; 2) participants will be provided with the rationale and instructions not to disclose their group assignment; 3) the study staff who conduct post-intervention assessments will not be given information about group assignment prior to the assessment; and 4) if a breach occurs, it will be documented and the participant will complete their assessment with a new assessor.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* prior diagnosis of Stage 0 to III breast cancer, DCIS or LCiS * received first breast cancer surgery (total or partial mastectomy, lumpectomy) at least 3 months ago * reports score of ≥3 in the past month on the 0 to 10 breast pain severity and/or interference scale * able to speak and read English * able to provide meaningful consent

Exclusion criteria

* \<18 years of age * hearing impairment that limits use of videoconferencing for intervention sessions * cognitive impairment that is documented in the medical record or results in being unable to provide meaningful consent

Design outcomes

Primary

MeasureTime frameDescription
Change in PEG Pain Severity and InterferenceBaseline, 3 months, 6 months, 12 monthsPersistent post-surgical pain burden 3-item measure: average pain intensity (P); interference with enjoyment in life (E); interference with general activity (G)

Secondary

MeasureTime frameDescription
Change in emotional distress: Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)Baseline, 3 months, 6 months, 12 monthsComposite score of 8-item assessment of depressive symptoms over the past two weeks and 7-item assessment of symptoms of anxiety over the past two weeks
Change in pain catastrophizing: Pain Catastrophizing Scale (PCS)Baseline, 3 months, 6 months, 12 months13-item assessment of the degree to which participants experience catastrophic thinking during painful experiences
Change in Central sensitization: Central Sensitization Inventory (CSI)Baseline, 3 months, 6 months, 12 months25-item questionnaire designed to measure hypersensitivity to senses and signs of central sensitization
Change in Central sensitization: Temporal summationBaseline, 6 months, 12 monthsDesigned to measure central pain mediation using weighted pinprick probes

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRebecca Shelby, PhD

Duke University

PRINCIPAL_INVESTIGATORDana Bovbjerg, PhD

University of Pittsburgh Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026